Researchers are excitedly investigating retatrutide, a promising medication developed by Eli Lilly, as a possible step in weight reduction . Different than many earlier approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, hormones that influence appetite and blood su… Read More